These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 180611

  • 1. [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases].
    Bauters F, Plouvier B, Breviere G, Goudemand M.
    Sem Hop; 1975 Jun 14; 51(28):1949-57. PubMed ID: 180611
    [Abstract] [Full Text] [Related]

  • 2. [Cardiotoxic effect of anthracycline antibiotics].
    Jovanović I, Ceranić LJ, Simeunović S, Cvetković P.
    Bilt Hematol Transfuz; 1983 Jun 14; 11(2-3):51-7. PubMed ID: 6680300
    [Abstract] [Full Text] [Related]

  • 3. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D, Hempel G, Fleischhack G, Schulz A, Boos J, Creutzig U.
    Klin Padiatr; 2002 Jun 14; 214(4):188-94. PubMed ID: 12165900
    [Abstract] [Full Text] [Related]

  • 4. Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up.
    Arbustini E, Gavazzi A, Dal Bello B, Morbini P, Campana C, Diegoli M, Grasso M, Fasani R, Banchieri N, Porcu E, Pilotto A, Ponzetta M, Bellini O, Lucreziotti S, Viganò M.
    G Ital Cardiol; 1997 Mar 14; 27(3):209-23. PubMed ID: 9199949
    [Abstract] [Full Text] [Related]

  • 5. Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: a 10-year experience.
    Sallan SE, Clavell LA.
    Semin Oncol; 1984 Dec 14; 11(4 Suppl 3):19-21. PubMed ID: 6594762
    [No Abstract] [Full Text] [Related]

  • 6. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C, Santamaria M, Galli MA, Jankovic M, Uderzo C.
    Pediatr Med Chir; 1987 Dec 14; 9(6):749-50. PubMed ID: 3481847
    [Abstract] [Full Text] [Related]

  • 7. Clinical studies with rubidazone.
    Benjamin RS, Keating MJ, Swenerton KD, Legha S, McCredie KB.
    Cancer Treat Rep; 1979 May 14; 63(5):925-9. PubMed ID: 287557
    [Abstract] [Full Text] [Related]

  • 8. [Studies on the cardiotoxicity of daunomycin in patients with acute leukemia].
    Marni E, Marchi A, Laini C, Zanol MG, Martini A, Livieri C, Genova R.
    Minerva Pediatr; 1978 Feb 28; 30(4):333-8. PubMed ID: 273716
    [No Abstract] [Full Text] [Related]

  • 9. [Polycardiographic evaluation of cardiotoxic effects of rubidomycin in patients with acute leukemia].
    Wodniecki J, Prochaczek F, Holowiecki J, Stella B.
    Acta Haematol Pol; 1976 Feb 28; 7(3):195-8. PubMed ID: 983667
    [Abstract] [Full Text] [Related]

  • 10. Time relationship between last dose of daunorubicin and congestive heart failure.
    Von Hoff DD, Layard M, Rozencweig M, Muggia FM.
    Cancer Treat Rep; 1977 Oct 28; 61(7):1411-3. PubMed ID: 271046
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Oct 28; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 12. Trial of daunomycin in acute promyelocytic leukemia of childhood: a Southwest Oncology Group Study.
    van Eys J, Steuber P, Haggard ME, Sabio H, Duncan M.
    Am J Pediatr Hematol Oncol; 1981 Oct 28; 3(3):301-3. PubMed ID: 7025685
    [Abstract] [Full Text] [Related]

  • 13. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.
    Pediatrics; 2004 Oct 28; 114(4):e469-76. PubMed ID: 15466073
    [Abstract] [Full Text] [Related]

  • 14. [57 cases of acute leukemia. Trial treatment with a semisynthetic daunorubicin derivative: 22,050 R.P].
    Bernard J, Jacquillat C, Boiron M, Weil M, Gémon MF, Izrael V, Schaison G, Delobel J.
    Nouv Presse Med; 1972 Sep 23; 1(33):2149-52. PubMed ID: 4507740
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.
    Feig SA, Ames MM, Sather HN, Steinherz L, Reid JM, Trigg M, Pendergrass TW, Warkentin P, Gerber M, Leonard M, Bleyer WA, Harris RE.
    Med Pediatr Oncol; 1996 Dec 23; 27(6):505-14. PubMed ID: 8888809
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Dec 23; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 17. [Acute leukemia. Case material and therapeutic results].
    Paolino W, Resegotti L, Rossi M, Infelise V, Degani GF.
    Minerva Med; 1975 May 09; 66(35):1642-52. PubMed ID: 1055305
    [Abstract] [Full Text] [Related]

  • 18. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J, Brincker H, Ellegaard J, Drivsholm A, Freund L, Jensen KB, Jensen MK, Nissen NI.
    Cancer Treat Rep; 1984 Oct 09; 68(10):1233-8. PubMed ID: 6597002
    [Abstract] [Full Text] [Related]

  • 19. "Just Another Statistic".
    Machtay M, Glatstein E.
    Oncologist; 1998 Oct 09; 3(3):III-IV. PubMed ID: 10388105
    [Abstract] [Full Text] [Related]

  • 20. Acute myeloid and lymphoblastic leukemia in adults. The course of the disease in 315 patients from one region, during a ten-year period.
    Johnsen HE, Bergmann OJ, Ellegaard J, Bastrup-Madsen P.
    Dan Med Bull; 1989 Apr 09; 36(2):189-93. PubMed ID: 2707057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.